Yahoo Finance • 2 months ago
CalciMedica, Inc. (NASDAQ:CALC), a small-cap biotech company valued at $42 million, saw Chief Medical Officer Sudarshan Hebbar report purchasing shares of the company’s common stock in two transactions, totaling $16,361. According to Inves... Full story
Yahoo Finance • 3 months ago
CalciMedica, Inc. (NASDAQ:CALC) CEO Leheny A. Rachel reported purchasing 2,500 shares of common stock on July 14, 2025, at a price of $2.47 per share. The total value of the purchase was $6,175. The purchase comes as the stock shows strong... Full story
Yahoo Finance • 3 months ago
[Wall Street sign in Lower Manhattan, NYC] georgeclerk Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MO... Full story
Yahoo Finance • 3 months ago
This article summarizes the most significant insider buys and sells reported on Thursday, July 10, 2025, for US stocks. Top Insider Buys: CalciMedica, Inc. (NASDAQ:CALC) saw director Eric W. Roberts purchase 5,000 shares of common stock... Full story
Yahoo Finance • 3 months ago
Eric W. Roberts, a director at CalciMedica, Inc. (NASDAQ:CALC), has recently purchased 5,000 shares of common stock at $1.6047 per share, close to the current trading price of $1.62. The total value of the purchase amounted to $8,023. This... Full story
Yahoo Finance • 3 months ago
Eric W. Roberts, a director and chief business officer at CalciMedica, Inc. (NASDAQ:CALC), recently purchased 4,500 shares of common stock. The transaction, which occurred on June 26, 2025, involved a purchase at a weighted average price o... Full story